These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27802188)

  • 1. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.
    Kim EH; Kim MS; Furusawa Y; Uzawa A; Han S; Jung WG; Sai S
    Oncotarget; 2016 Dec; 7(49):80568-80578. PubMed ID: 27802188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
    Gong L; Jin X; Li Q; Liu J; An L
    Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.
    Abdelmonsif DA; Sultan AS; El-Hadidy WF; Abdallah DM
    Mol Diagn Ther; 2018 Feb; 22(1):115-127. PubMed ID: 29094287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell.
    Xie Y; Si J; Wang YP; Li HY; Di CX; Yan JF; Ye YC; Zhang YS; Zhang H
    J Cell Physiol; 2018 Feb; 233(2):1312-1320. PubMed ID: 28500630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
    Liu B; Chen W; Li H; Li F; Jin X; Li Q
    Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low and high linear energy transfer radiation sensitization of HCC cells by metformin.
    Kim EH; Kim MS; Cho CK; Jung WG; Jeong YK; Jeong JH
    J Radiat Res; 2014 May; 55(3):432-42. PubMed ID: 24375278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition.
    Zhang KF; Wang J; Guo J; Huang YY; Huang TR
    J Cancer Res Ther; 2019; 15(7):1603-1610. PubMed ID: 31939444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway.
    Tan B; Huang Y; Zhang B; Lin N
    Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
    Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway.
    Xiong Y; Lu QJ; Zhao J; Wu GY
    Asian Pac J Cancer Prev; 2012; 13(7):3275-9. PubMed ID: 22994747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.
    Kubo N; Noda SE; Takahashi A; Yoshida Y; Oike T; Murata K; Musha A; Suzuki Y; Ohno T; Takahashi T; Nakano T
    J Radiat Res; 2015 Mar; 56(2):229-38. PubMed ID: 25599995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
    Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
    Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam.
    Xue L; Furusawa Y; Yu D
    DNA Repair (Amst); 2015 Oct; 34():1-8. PubMed ID: 26246317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress.
    Cuneo KC; Morgan MA; Davis MA; Parcels LA; Parcels J; Karnak D; Ryan C; Liu N; Maybaum J; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):782-90. PubMed ID: 26975930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair.
    Wang Z; Lai ST; Ma NY; Deng Y; Liu Y; Wei DP; Zhao JD; Jiang GL
    Cancer Lett; 2015 Dec; 369(1):192-201. PubMed ID: 26304716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein Enhances Radiosensitivity of Human Hepatocellular Carcinoma Cells by Inducing G2/M Arrest and Apoptosis.
    Yan H; Jiang J; Du A; Gao J; Zhang D; Song L
    Radiat Res; 2020 Mar; 193(3):286-300. PubMed ID: 32017668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Linear Energy Transfer Affect Cell-killing and Radiosensitizing Effects of Spread-out Carbon-ion Beams.
    Shiba S; Wakatsuki M; Ohno T; Nakano T
    Anticancer Res; 2020 Oct; 40(10):5497-5502. PubMed ID: 32988872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.